ES2127699B1 - Nuevos derivados de 2,3-benzodiazepina. - Google Patents

Nuevos derivados de 2,3-benzodiazepina.

Info

Publication number
ES2127699B1
ES2127699B1 ES009700703A ES9700703A ES2127699B1 ES 2127699 B1 ES2127699 B1 ES 2127699B1 ES 009700703 A ES009700703 A ES 009700703A ES 9700703 A ES9700703 A ES 9700703A ES 2127699 B1 ES2127699 B1 ES 2127699B1
Authority
ES
Spain
Prior art keywords
sup
group
sub
alkyl
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
ES009700703A
Other languages
English (en)
Other versions
ES2127699A1 (es
Inventor
Istvan Ling
Gizella Abraham
Pal Berzsenyi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Egyt Gyogyszervegyeszeti Gyar
Egis Pharmaceuticals PLC
Original Assignee
Egyt Gyogyszervegyeszeti Gyar
Egis Pharmaceuticals PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from HU9600871A external-priority patent/HU9600871D0/hu
Application filed by Egyt Gyogyszervegyeszeti Gyar, Egis Pharmaceuticals PLC filed Critical Egyt Gyogyszervegyeszeti Gyar
Publication of ES2127699A1 publication Critical patent/ES2127699A1/es
Application granted granted Critical
Publication of ES2127699B1 publication Critical patent/ES2127699B1/es
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/02—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Nuevos derivados de 2,3-benzodiazepina La invención se refiere a compuestos antagonistas AMPA no competitivos de fórmula I, en la que R{sup,1 y R{sup,2 representan, independientemente, un hidrógeno, un halógeno, un grupo C{sub,1-4 -alquilo, un grupo C{sub,1-4 -alcoxilo, un grupo nitro, un grupo trifluoro-metilo o un grupo de amina secundaria R{sup,3 representa un grupo C{sub,1-4 -alquilo, un grupo C{sub,3-5 -cicloalquilo o un grupo cetocarbonilo R{sup,4 y R{sup,5 significan, independientemente, un hidrógeno o un grupo C{sub,1-3 alquilo, R{sup,6 y R{sup,7 son, independientemente, un hidrógeno, un cloro o un bromo. así como a los isómeros y las sales de adición de ácido de los compuestos o los isómeros, y a las composiciones farmacéuticas preparadas a partir de cualquiera de ellos. La invención se refiere también a los compuestos de partida de fórmula II, en, la que R{sup,1 , R{sup,2 , R{sup,4 , R{sup,5 , R{sup,6 y R{sup,7 tienen el significado indicado en relación con la fórmula I.
ES009700703A 1996-04-04 1997-04-04 Nuevos derivados de 2,3-benzodiazepina. Expired - Fee Related ES2127699B1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU9600871A HU9600871D0 (en) 1996-04-04 1996-04-04 New 2,3-benzodiazepine derivatives

Publications (2)

Publication Number Publication Date
ES2127699A1 ES2127699A1 (es) 1999-04-16
ES2127699B1 true ES2127699B1 (es) 2000-01-16

Family

ID=89993864

Family Applications (1)

Application Number Title Priority Date Filing Date
ES009700703A Expired - Fee Related ES2127699B1 (es) 1996-04-04 1997-04-04 Nuevos derivados de 2,3-benzodiazepina.

Country Status (11)

Country Link
KR (1) KR970069997A (es)
AT (1) ATE254608T1 (es)
AU (1) AU720745B2 (es)
BE (1) BE1010962A4 (es)
DE (1) DE59711013D1 (es)
ES (1) ES2127699B1 (es)
IT (1) IT1290453B1 (es)
NZ (1) NZ314517A (es)
UA (1) UA45358C2 (es)
YU (1) YU13197A (es)
ZA (1) ZA972746B (es)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU179018B (en) * 1978-10-19 1982-08-28 Gyogyszerkutato Intezet Process for producing new 5h-2,3-benzodiazepine derivatives
HU186760B (en) * 1981-03-12 1985-09-30 Gyogyszerkutato Intezet Process for preparing 3,4-dihydro-5h-2,3-aenzodiazepine derivatives
HU219778B (hu) * 1990-12-21 2001-07-30 Gyógyszerkutató Intézet Közös Vállalat Eljárás N-acil-2,3-benzodiazepin-származékok, savaddíciós sóik és az ezeket tartalmazó gyógyászati készítmények előállítására, valamint a vegyületek egy csoportja, és az ezeket tartalmazó gyógyászati készítmények
HU208429B (en) * 1991-05-03 1993-10-28 Gyogyszerkutato Intezet Process for producing 1-/3-chloro-phenyl/-4-methyl-7,8-dimethoxy-5h-2,3-benzodiazepine of high purity
DK1157992T3 (da) * 1994-08-31 2005-10-24 Lilly Co Eli Dihydro-2,3-benzodiazepinederivativer

Also Published As

Publication number Publication date
KR970069997A (ko) 1997-11-07
ITMI970776A1 (it) 1998-10-04
AU720745B2 (en) 2000-06-08
DE59711013D1 (de) 2003-12-24
BE1010962A4 (fr) 1999-03-02
ES2127699A1 (es) 1999-04-16
UA45358C2 (uk) 2002-04-15
ATE254608T1 (de) 2003-12-15
AU1773497A (en) 1997-10-09
IT1290453B1 (it) 1998-12-03
ZA972746B (en) 1998-10-09
NZ314517A (en) 2000-03-27
YU13197A (sh) 1999-09-27

Similar Documents

Publication Publication Date Title
GT199800180A (es) Derivados de la tienopirimidina y de la tienopiridina utiles como agentes anticancerigenos.
ES2160648T3 (es) Derivados de piridina.
GT200100137A (es) Pro-drogas de derivados de 4-fenil-piridina.
SV2002000478A (es) Derivados de tiofeno utiles como anticancerosos ref. pc10795aagl/bb
AR009938A1 (es) Nuevos derivados de arilglicinamida, procedimientos para su preparacion y composiciones farmaceuticas que contienen estos compuestos
AR029216A1 (es) Compuestos inhibidores no peptidicos de la union celular dependiente de vla-4 utiles en el tratamiento de enfermedades inflamatorias, autoinmunes y respiratorias; composicion farmaceutica y procedimiento de tratamiento
ES2053508T3 (es) Compuestos de acidos 3-pirrolidinil-tio-1-azabiciclo(3.2.0)hept-2-eno-2-carboxilicos.
AR016877A2 (es) 6-ter-butiloxicarbonilaminopiridinas 2-sustituidas y sus sales
PA8547901A1 (es) Derivados de 4-piperacinilindol con afinidad receptora de 5-ht6
YU8703A (sh) Derivati 4-fenil-piridina kao antagonisti receptora neurokinina-1
TR200100698T2 (tr) 5-HT4 alıcı-Antagonistleri olarak Dihidrobenzodioksin Karboksamit ve Keton türevleri
NO20050612L (no) Pyrrolidinderivater som oksytocinantagonister
PA8589801A1 (es) Aminoalcoxiindoles
TR200101711T2 (tr) Antihistaminik spiro bileşikler.
EA199700030A2 (ru) Новые производные 2,3-бензодиазепина
ES2167021T3 (es) Derivados de acido 4-bifenil-4-hidroxibutirico sustituidos como inhibidores de metaloproteasa de matriz.
BG106847A (en) Substituted piperazine derivatives as mtp inhibitors
MX9304424A (es) Bencimidazoles, medicamentos que contienen estos compuestos y procedimiento para su preparacion.
ES2148458T3 (es) Derivados de fenil-4-tiazoles sustituidos, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
UY27034A1 (es) Derivados de pirimidina
ES2029879T3 (es) Procedimiento para producir derivados de aminas sustituidas.
ES2127699B1 (es) Nuevos derivados de 2,3-benzodiazepina.
ES2143630T3 (es) Derivados azabicicloalquilos de imidazo(1,5-a)indol-3-ona utilizados como antagonistas de 5ht3.
AR033429A1 (es) Derivados del acido alcoxicarbonilamino-heteroarilcarboxilico, su uso, un procedimiento para prepararlos y composiciones farmaceuticas que los comprenden
ES2172023T3 (es) Nuevos derivados tetrahidro-piridinicos sustituidos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 19990416

Kind code of ref document: A1

Effective date: 19990416

FD1A Patent lapsed

Effective date: 20040405